Sukcesywne dostawy produktów farmaceutycznych dla Szpitali Pomorskich Sp. z o.o. - produkty farmaceutyczne – programy lekowe 2026v62
6 suppliers awarded•15 lots awarded•€1.76M awarded
Buyer: Szpitale Pomorskie Sp. z o.o. / Gdynia, Poland
Awarded value
€1.76M
Estimated value
€1.76M
Awarded at 100% of estimated value
Award date
May 31, 2026
Winners
6
Lots awarded
15
Award values
Notice total
€1.76M
Sum of lot awards
€1.96M
TED notice total and lot-level values do not exactly match.
Winners
Warszawa, POL
€563,832 This contract
89 award notices•230 awarded lots•€41.52M total
Warszawa, POL
€495,501 This contract
23 award notices•40 awarded lots•€13.4M total
Warszawa, POL
€468,767 This contract
14 award notices•21 awarded lots•€14.76M total
Warszawa, POL
€238,846 This contract
37 award notices•69 awarded lots•€65.25M total
Warszawa, POL
€49,290 This contract
26 award notices•49 awarded lots•€32.2M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0033 | InPharm Sp. z o. o. | €335,678 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0039 | InPharm Sp. z o. o. | €228,154 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0040 | BAXTER POLSKA Sp. z o.o. | €200,447 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0041 | Abbvie Sp. z o.o. | €200,447 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0038 | Abbvie Sp. z o.o. | €155,893 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0035 | BAXTER POLSKA Sp. z o.o. | €147,867 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0036 | BAXTER POLSKA Sp. z o.o. | €147,187 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0043 | CENTRALA FARMACEUTYCZNA CEFARM SA | €143,392 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0037 | Abbvie Sp. z o.o. | €112,427 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0034 | CENTRALA FARMACEUTYCZNA CEFARM SA | €95,454 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0044 | Lek S. A. | €66,425 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0042 | Lek S. A. | €45,492 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0045 | Not specified | €32,001 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0031 | Janssen - Cilag Polska sp. z o.o. | €24,797 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0032 | Janssen - Cilag Polska sp. z o.o. | €24,493 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) |